UnitedHealth Group (NYSE:UNH) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.

Key Points

• Representative Gilbert Ray Cisneros, Jr. purchased between $1,001 and $15,000 in UnitedHealth Group stock on September 5th, as disclosed on October 10th.
• UnitedHealth Group's stock recently traded at $359.70 with a market cap of $325.77 billion and a P/E ratio of 15.58.
• The company announced a quarterly dividend of $2.21 per share, reflecting an annualized dividend of $8.84 and a yield of 2.5%.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on October 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on September 5th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of StandardAero NYSE: SARO on 10/1/2025.
• Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 10/1/2025.
• Purchased $1,001 - $15,000 in shares of Waters NYSE: WAT on 9/30/2025.
• Sold $15,001 - $50,000 in shares of Fortive NYSE: FTV on 9/30/2025.
• Purchased $1,001 - $15,000 in shares of StandardAero NYSE: SARO on 9/30/2025.
• Purchased $1,001 - $15,000 in shares of APi Group NYSE: APG on 9/30/2025.
• Sold $1,001 - $15,000 in shares of GoDaddy NYSE: GDDY on 9/30/2025.
• Purchased $1,001 - $15,000 in shares of PTC NASDAQ: PTC on 9/30/2025.
• Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 9/30/2025.
• Purchased $1,001 - $15,000 in shares of Mitsubishi Heavy Industries OTCMKTS: MHVYF on 9/30/2025.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $1.04 on Tuesday, hitting $359.70. The stock had a trading volume of 5,946,984 shares, compared to its average volume of 12,656,982. The company's 50 day moving average price is $320.57 and its 200 day moving average price is $346.99. The stock has a market cap of $325.77 billion, a price-to-earnings ratio of 15.58, a P/E/G ratio of 2.29 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's quarterly revenue was up 12.9% on a year-over-year basis. During the same period last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is 38.30%.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently made changes to their positions in UNH. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its position in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Geode Capital Management LLC increased its position in shares of UnitedHealth Group by 3.3% in the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock valued at $6,624,411,000 after buying an additional 675,075 shares in the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $3,837,207,000. Finally, Dodge & Cox raised its position in UnitedHealth Group by 117.7% during the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after acquiring an additional 4,730,192 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Mizuho raised their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a research report on Thursday, October 9th. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Truist Financial lifted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research note on Tuesday, September 9th. The Goldman Sachs Group initiated coverage on UnitedHealth Group in a report on Tuesday. They set a "buy" rating and a $406.00 price target for the company. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $384.09.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.